← All trials
NCT06946589
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 1, 2025
- Primary completion
- Aug 1, 2026
- Completion date
- Sep 1, 2027
- First posted
- Apr 27, 2025
- Last posted
- Apr 27, 2025
- Enrollment
- 200
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Queen's University, BelfastLead sponsor
- Queen's University, BelfastOfficial
- Queen's University, BelfastSponsor investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.